B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy | MicrobiomeTrials← Back to trialsNCT07271966
B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-05-29Est. Completion: 2027-05-31
Enrollment target: 50 participants Locations- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Brain Tumor Related Epilepsy (BTRE)
This study is being conducted to find out whether lacosamide (a drug to treat epilepsy) is effective in routine clinical…
Lille, FranceCompleted Dec 4, 2017